How Can Nurses Stay Informed About New Medications and Treatments?
Staying informed as a nursing professional is an ongoing objective. With ground-breaking, life-changing clinical research occurring constantly around the world,... Read more.
Viagra vs. Generic Sildenafil for Erectile Dysfunction
Erectile dysfunction (ED) affects millions of men worldwide, and while Viagra is a household name in addressing this issue, generic sildenafil presents a cost-effective... Read more.
Cipla Initiates Voluntary Recall of Vigabatrin for Oral Solution Due to Seal Integrity Issues
Cipla Limited, a global pharmaceutical company, has announced the voluntary recall of one lot of Vigabatrin for Oral Solution, USP 500mg, by its wholly-owned subsidiary,... Read more.
Global Gene Therapy Market Expected to Surge by USD 4,613.9 Million from 2022 to 2027
The global gene therapy market is anticipated to witness substantial growth, with Technavio projecting a robust increase of USD 4,613.9 million between 2022 and... Read more.
Scinai’s Aerosolized NanoAbs: Promising COVID-19 Prophylactic and Therapeutic, Study Finds
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products, has announced... Read more.
Federal Judge Allows Lawsuit Over Ozempic Side Effects to Proceed
In a recent development, a federal judge in Louisiana has ruled against Novo Nordisk’s attempt to dismiss one of the earliest Ozempic lawsuits concerning the... Read more.
Disappointment As Study Reveals Weight Regain in Patients After Discontinuation of Eli Lilly’s Zepbound
In a significant development, the full results of a study published in the journal JAMA on Monday have unveiled that patients undergoing treatment with Eli Lilly’s... Read more.
Myanmar Emerges as World’s Largest Opium Source Amid Afghan Decline, UN Reports
In a startling revelation, Myanmar has now claimed the dubious distinction of being the world’s largest source of opium, surpassing Afghanistan, according... Read more.
US Consumer Group Urges FDA to Strengthen Warnings on Botox and Similar Treatments
In a move aimed at enhancing consumer safety, Public Citizen, a prominent consumer advocacy group, has submitted a petition to the U.S. Food and Drug Administration... Read more.
Shuttle Pharma Submits Ropidoxuridine IND for Glioblastoma Treatment to FDA
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”) has announced a significant stride in its mission to address glioblastoma, a... Read more.